Connection

Jean-Charles Soria to Drug-Related Side Effects and Adverse Reactions

Back to Details
This is a "connection" page, showing publications Jean-Charles Soria has written about Drug-Related Side Effects and Adverse Reactions.
Jean-Charles Soria
Connection Strength
0.213
Drug-Related Side Effects and Adverse Reactions
  1. Challenges in lung cancer therapy during the COVID-19 pandemic. Lancet Respir Med. 2020 06; 8(6):542-544.
    View in: PubMed
    Score: 0.100
  2. First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity. Eur J Cancer. 2019 03; 109:103-110.
    View in: PubMed
    Score: 0.092
  3. Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies. Clin Cancer Res. 2017 Nov 01; 23(21):6411-6420.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.